Kura Oncology Inc (FRA:KUR)
€ 18.41 -0.035 (-0.19%) Market Cap: 1.41 Bil Enterprise Value: 938.19 Mil PE Ratio: 0 PB Ratio: 3.02 GF Score: 36/100

Kura Oncology Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 09:30PM GMT
Release Date Price: €30.6 (-3.77%)
Unidentified Analyst

Good afternoon, everybody. Thank you for joining us today. On behalf of the entire JPMorgan Healthcare team, it is my pleasure to introduce you to Troy Wilson, President and CEO of Kura Oncology. Just as a friendly reminder, you may submit your questions through the ask a Q feature listed under the presentation. Thank you for your participation. And I'll now hand it off to Troy. Thank you again.

Troy Edward Wilson
Kura Oncology, Inc. - Chairman, CEO & President

Thank you, [Amy], and thank you to our colleagues at JPMorgan for the invitation to present in today's conference. It's unfortunate that we're not able to see many of you in person, but we're going to do the best we can today and give you an update on all of the progress that we've been making at Kura Oncology over the last year and to look forward to what you'll see in 2021 and beyond. And again, I want to thank JPMorgan for this opportunity.

I'm going to be calling out slide numbers for those of you who are following along. And so we'll start with just a quick forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot